Literature DB >> 21632248

Evaluation of a cell penetrating prenylated peptide lacking an intrinsic fluorophore via in situ click reaction.

Joshua D Ochocki1, Daniel G Mullen, Elizabeth V Wattenberg, Mark D Distefano.   

Abstract

Protein prenylation involves the addition of either a farnesyl (C(15)) or geranylgeranyl (C(20)) isoprenoid moiety onto the C-terminus of many proteins. This natural modification serves to direct a protein to the plasma membrane of the cell. A recently discovered application of prenylated peptides is that they have inherent cell-penetrating ability, and are hence termed cell penetrating prenylated peptides. These peptides are able to efficiently cross the cell membrane in an ATP independent, non-endocytotic manner and it was found that the sequence of the peptide does not affect uptake, so long as the geranylgeranyl group is still present [Wollack, J. W.; Zeliadt, N. A.; Mullen, D. G.; Amundson, G.; Geier, S.; Falkum, S.; Wattenberg, E. V.; Barany, G.; Distefano, M. D. Multifunctional Prenylated Peptides for Live Cell Analysis. J. Am. Chem. Soc.2009, 131, 7293-7303]. The present study investigates the effect of removing the fluorophore from the peptides and investigating the uptake by confocal microscopy and flow cytometry. Our results show that the fluorophore is not necessary for uptake of these peptides. This information is significant because it indicates that the prenyl group is the major determinant in allowing these peptides to enter cells; the hydrophobic fluorophore has little effect. Moreover, these studies demonstrate the utility of the Cu-catalyzed click reaction for monitoring the entry of nonfluorescent peptides into cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632248      PMCID: PMC3266054          DOI: 10.1016/j.bmcl.2011.04.138

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

1.  Farnesyltransferase inhibitors in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Jorge Cortes
Journal:  Clin Lymphoma       Date:  2003-08

Review 2.  Biochemistry of protein prenylation.

Authors:  P J Casey
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

Review 3.  Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I.

Authors:  Kimberly T Lane; Lorena S Beese
Journal:  J Lipid Res       Date:  2006-02-13       Impact factor: 5.922

4.  Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides.

Authors:  Igor L Medintz; Thomas Pons; James B Delehanty; Kimihiro Susumu; Florence M Brunel; Philip E Dawson; Hedi Mattoussi
Journal:  Bioconjug Chem       Date:  2008-08-06       Impact factor: 4.774

Review 5.  Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

Authors:  Roy Blum; Yoel Kloog
Journal:  Drug Resist Updat       Date:  2005-12-13       Impact factor: 18.500

Review 6.  Inhibitors of protein farnesyltransferase as novel anticancer agents.

Authors:  Junko Ohkanda; David B Knowles; Michelle A Blaskovich; Said M Sebti; Andrew D Hamilton
Journal:  Curr Top Med Chem       Date:  2002-03       Impact factor: 3.295

Review 7.  Protein farnesyltransferase inhibitors.

Authors:  Semiramis Ayral-Kaloustian; Edward J Salaski
Journal:  Curr Med Chem       Date:  2002-05       Impact factor: 4.530

Review 8.  Farnesyltransferase inhibitors as anticancer agents: current status.

Authors:  Kuichun Zhu; Andrew D Hamilton; Saïd M Sebti
Journal:  Curr Opin Investig Drugs       Date:  2003-12

Review 9.  Genetic analyses of the role of RCE1 in RAS membrane association and transformation.

Authors:  Martin O Bergo; Annika M Wahlstrom; Loren G Fong; Stephen G Young
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

10.  Functional analysis of Arabidopsis postprenylation CaaX processing enzymes and their function in subcellular protein targeting.

Authors:  Keren Bracha-Drori; Keren Shichrur; Tsofnat Cohen Lubetzky; Shaul Yalovsky
Journal:  Plant Physiol       Date:  2008-07-18       Impact factor: 8.340

View more
  8 in total

1.  Cathepsin-Mediated Cleavage of Peptides from Peptide Amphiphiles Leads to Enhanced Intracellular Peptide Accumulation.

Authors:  Handan Acar; Ravand Samaeekia; Mathew R Schnorenberg; Dibyendu K Sasmal; Jun Huang; Matthew V Tirrell; James L LaBelle
Journal:  Bioconjug Chem       Date:  2017-08-24       Impact factor: 4.774

2.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.

Authors:  Zhengrong Guo; Huanyan Peng; Jiwen Kang; Dianxing Sun
Journal:  Biomed Rep       Date:  2016-03-23

Review 3.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

4.  A bicyclic peptide scaffold promotes phosphotyrosine mimicry and cellular uptake.

Authors:  Justin S Quartararo; Matthew R Eshelman; Leila Peraro; Hongtao Yu; James D Baleja; Yu-Shan Lin; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

Review 5.  Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review.

Authors:  Idris Zubairu Sadiq; Aliyu Muhammad; Sanusi Bello Mada; Bashiru Ibrahim; Umar Aliyu Umar
Journal:  Tissue Barriers       Date:  2021-10-25

Review 6.  Emerging Methods and Design Principles for Cell-Penetrant Peptides.

Authors:  Leila Peraro; Joshua A Kritzer
Journal:  Angew Chem Int Ed Engl       Date:  2018-08-17       Impact factor: 15.336

Review 7.  In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.

Authors:  Jinsha Liu; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

8.  Derivatisable Cyanobactin Analogues: A Semisynthetic Approach.

Authors:  Emilia Oueis; Catherine Adamson; Greg Mann; Hannes Ludewig; Philip Redpath; Marie Migaud; Nicholas J Westwood; James H Naismith
Journal:  Chembiochem       Date:  2015-11-10       Impact factor: 3.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.